var data={"title":"Talc (sterile): Drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Talc (sterile): Drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/8189?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=talc-sterile-patient-drug-information\" class=\"drug drug_patient\">see &quot;Talc (sterile): Patient drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F6021564\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>Sclerosol Intrapleural;</li>\n      <li>Sterile Talc Powder</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F6021566\" class=\"ex_sect_xr thclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Pharmacologic Category</span>\n    <ul>\n      <li>\n        Sclerosing Agent</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F6021773\" class=\"block doa drugH1Div\"><span class=\"drugH1\">Dosing: Adult</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Pleural effusion, malignant:</b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Intrapleural aerosol: 4 to 8 g (1 to 2 cans) as a single dose</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Intrapleural suspension:</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Sterile Talc Powder: 5 g</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Steritalc: 2 to 5 g (based on patient condition other doses may be used); maximum cumulative dose: 10 g</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Pneumothorax: </b>Intrapleural: Steritalc: 2 g (based on patient condition other doses may be used); maximum cumulative dose: 10 g</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F25316085\" class=\"block dor drugH1Div\"><span class=\"drugH1\">Dosing: Renal Impairment</span>\n    <p style=\"text-indent:0em;\">There are no dosage adjustments provided in the manufacturer's labeling. </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F25316086\" class=\"block doh drugH1Div\"><span class=\"drugH1\">Dosing: Hepatic Impairment</span>\n    <p style=\"text-indent:0em;\">There are no dosage adjustments provided in the manufacturer's labeling. </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F247656\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Aerosol Powder, Intrapleural: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Sclerosol Intrapleural: 4 g (30 g) [contains dichlorodifluoromethane]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Suspension Reconstituted, Intrapleural: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Sterile Talc Powder: 5 g (1 ea)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F20452410\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Equivalent Available (US)</span>\n    <p style=\"text-indent:0em;display:inline\">No</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F6021774\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:0em;display:inline\">For intrapleural (pleurodesis) administration only; <b>not for IV administration</b>. Administer after adequate drainage of the effusion or air.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Sclerosol Intrapleural Aerosol: Shake well and attach delivery tube. Insert delivery tube through pleural trocar, manually press on actuator button of canister to release; point in several different directions to distribute to all pleural surfaces. Keep canister in an upright position for optimal distribution. Rate of delivery is 1.2 g per second.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Sterile Talc Powder: Administer as a suspension. Shake well before instillation. Vent the10 mL air headspace and empty contents of each syringe into chest cavity through the chest tube by gently applying pressure to syringe plunger. After administration, clamp the chest tube for 1 to 2 hours and then drain the pleural fluid; the chest tube can be removed when drainage is &lt;100 to 150 mL/24 hours (Dresler 2005; Kvale 2007).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Steritalc:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Slurry for tube thoracostomy: Shake syringe well prior to administration to redisperse talc and avoid settling. Immediately prior to administration, vent the 10 mL air headspace from each syringe and administer talc suspension through the chest tube (follow standard procedures). Inject slurry through pleural drainage into pleural cavity; clamp pleural drainage and retain negative pressure in the pleural cavity. With slurry in cavity, re-position patient regularly to achieve even slurry distribution. Aspirate slurry through pleural drainage.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Insufflation/poudrage: Perform procedure with a tube thoracoscopy. Follow device instructions for insufflation or poudrage. After use, some talc may remain in the vial (discard unused portion).</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">\n      <i>2 or 4 g vials:</i> Introduce cannula into trocar, distribute talc evenly in pleural cavity by spraying several times and changing cannula direction every few sprays.</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">\n      <i>3 g vial:</i> Keep product upright during use; avoid contact between the cannula tip and tissue or body fluids (may result in blocked cannula; if blockage occurs, shorten cannula with a scalpel, cutting perpendicular to cannula and ensuring the cut edge is straight and smooth). Proceed with intervention by introducing cannula into the trocar, distribute the talc evenly in the pleural cavity by pressing insufflation bulb carefully and at regular intervals. After spraying a few times, change the cannula direction.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F247657\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Pleural effusion, malignant:</b> Sclerosing agent to decrease or prevent the recurrence of malignant pleural effusion in symptomatic patients (following maximal drainage of pleural effusion).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Pneumothorax:</b> Sclerosing agent to decrease the recurrence of pneumothorax.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F247653\" class=\"block adr drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:0em;display:inline\">Frequency not defined.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Cardiovascular: Chest pain, hypotension (transient), myocardial infarction, pulmonary embolism, tachycardia</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Endocrine &amp; metabolic: Hypovolemia</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Hematologic &amp; oncologic: Local hemorrhage</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Infection: Infection (at administration site)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Local: Local pain</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Respiratory: Adult respiratory distress syndrome (ARDS), bronchopleural fistula, dyspnea, empyema (including subcutaneous empyema), hemoptysis, hypoxemia, pneumonia, pulmonary edema</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Miscellaneous: Fever (generally lasting &lt;24 hours)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F6021570\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Steritalc:</b> Pregnancy.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Sclerosol, Sterile Talc Powder:</b> There are no contraindications listed in the manufacturer's labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F6021571\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Concerns related to adverse effects:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Pulmonary effects: Acute pneumonitis and acute respiratory distress syndrome (ARDS), including fatalities have been reported with intrapleural sterile talc; most cases of ARDS occurred with talc doses of 10 g via a chest tube. Systemic sterile talc exposure may be affected by the visceral pleura integrity and may be increased if sterile talc is administered following mechanical pleura abrasion or biopsy. Talc particle size distribution may correlate with the risk of toxicities. Products are for intrapleural use only; IV administration (not recommended) is associated with pulmonary hypertension and lung parenchymal disease. Silicosis or asbestosis-like conditions (chronic bronchitis, bronchogenic carcinoma, and pleural plaques) are associated with inhaled talc.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Dosage form specific issues:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Sclerosol: Contents under pressure and should be kept away from any heat source or open flame; do not puncture canister.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Steritalc: Lead exposure: Steritalc contains lead (as an impurity). The primary target organ for lead toxicity is the central nervous system, although lead exposure may also have an impact on blood pressure, renal function, anemia, and male fertility. The threshold for minimum risk exposure levels has not been fully established in humans. Pediatric patients are more sensitive to lead toxicity (than adults); a safe blood level has not been established in children. Cognitive and neurobehavioral deficits are observed in children exposed to lead. Lead exposure during pregnancy may also cause adverse events.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Other warnings/precautions:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Appropriate use: Should not be used for potentially curable malignancies where systemic therapy would be more appropriate (sterile talc does not have antineoplastic activity). Clinicians should evaluate need for future diagnostic or surgical procedures before use; sclerosis of pleural space may preclude or complicate subsequent ipsilateral surgery and diagnostic procedures (eg, pneumonectomy for transplantation).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F6021567\" class=\"block prf drugH1Div\"><span class=\"drugH1\">Pregnancy Risk Factor</span>\n    <p style=\"text-indent:0em;display:inline\">B (manufacturer specific) (<a href=\"image.htm?imageKey=DRUG%2F50021\" class=\"graphic graphic_table\">show table</a>)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F6021568\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">Steritalc is contraindicated in pregnancy; Steritalc contains lead (as an impurity); lead exposure during pregnancy may result in miscarriage, premature birth, low birth weights, and slow/impaired mental childhood development. Women of reproductive potential should use effective contraception during Steritalc treatment and for 5 months following the final Steritalc dose. Steritalc may impair fertility in males (decreased sperm production).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Adverse events were not observed in animal reproduction studies following oral administration with other sterile talc formulations; use during pregnancy only if clearly needed.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F25316061\" class=\"block brc drugH1Div\"><span class=\"drugH1\">Breast-Feeding Considerations</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">It is not known if sterile talc is present in breast milk.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Steritalc contains lead (as an impurity), which is known to have an adverse effect on health and development in neonates, infants, and children. Due to the potential for serious adverse reactions resulting from lead exposure in the breastfed infant, lactating women should avoid breastfeeding during Steritalc treatment and for 5 months following the final Steritalc dose.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F6021771\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">Sterile talc instilled into the pleural cavity induces an inflammatory reaction, promoting adherence of the visceral and parietal pleura, therefore, preventing reaccumulation of pleural air or fluid.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F25316083\" class=\"block phk drugH1Div\"><span class=\"drugH1\">Pharmacodynamics/Kinetics</span>\n    <p style=\"text-indent:0em;display:inline\">Absorption: Not well studied; systemic exposure may be influenced by integrity of visceral pleura</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F16323637\" class=\"block fee drugH1Div\"><span class=\"drugH1\">Pricing: US</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Aerosol powder</b> (Sclerosol Intrapleural Intrapleural)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">4 g (30 g): $126.00</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suspension (reconstituted)</b> (Sterile Talc Powder Intrapleural)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">5 g (1): $97.50</p>\n    <p style=\"text-indent:0em;\">\n      <b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    Dresler CM, Olak J, Herndon JE, et al, &ldquo;Phase III Intergroup Study of Talc Poudrage Vs Talc Slurry Sclerosis for Malignant Pleural Effusion,&rdquo; <i>Chest</i>, 2005, 127(3):909-15.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/talc-sterile-drug-information/abstract-text/15764775/pubmed\" target=\"_blank\" id=\"15764775\">15764775</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Kvale PA, Seleecky PA, and Prakash UB, &ldquo;Palliative Care in Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition),&rdquo; <i>Chest</i>, 2007, 132(3 Suppl):368-403.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/talc-sterile-drug-information/abstract-text/17873181/pubmed\" target=\"_blank\" id=\"17873181\">17873181</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Sclerosol intrapleural aerosol (sterile talc) [prescribing information]. Woburn, MA: Bryan Corporation; October 2012.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Sterile Talc Powder (sterile talc powder) [prescribing information]. Woburn, MA: Bryan Corporation; June 2014.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Steritalc (sterile talc powder) [prescribing information]. La Ciotat Cedex, France: Novatech SA; May 2017.</div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 9496 Version 69.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F6021564\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacologic Category\" href=\"#F6021566\" class=\"outlineLink\">Pharmacologic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Adult\" href=\"#F6021773\" class=\"outlineLink\">Dosing: Adult</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Renal Impairment\" href=\"#F25316085\" class=\"outlineLink\">Dosing: Renal Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Hepatic Impairment\" href=\"#F25316086\" class=\"outlineLink\">Dosing: Hepatic Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F247656\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Equivalent Available (US)\" href=\"#F20452410\" class=\"outlineLink\">Generic Equivalent Available (US)</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F6021774\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F247657\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F247653\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F6021570\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F6021571\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Risk Factor\" href=\"#F6021567\" class=\"outlineLink\">Pregnancy Risk Factor</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F6021568\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Breast-Feeding Considerations\" href=\"#F25316061\" class=\"outlineLink\">Breast-Feeding Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F6021771\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacodynamics/Kinetics\" href=\"#F25316083\" class=\"outlineLink\">Pharmacodynamics/Kinetics</a></li><li class=\"plainItem\"><a sectionName=\"Pricing: US\" href=\"#F16323637\" class=\"outlineLink\">Pricing: US</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_GEN/9496|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=talc-sterile-patient-drug-information\" class=\"drug drug_patient\">Talc (sterile): Patient drug information</a></li></ul></div></div>","javascript":null}